| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed and Relapsed Amyloid Light Chain Amyloidosis: A Single-Center Experience
|
Jimenez-Zepeda, Victor H.
|
|
2016
|
16 |
6 |
p. e79-e84
nvt p.
|
artikel
|
| 2 |
Can We Cure Light Chain Deposition Disease of the Kidneys?—A Review and Case Report of a Patient Treated With a Triple Transplant Approach
|
Sivaraj, Dharshan
|
|
2016
|
16 |
6 |
p. e95-e100
nvt p.
|
artikel
|
| 3 |
Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic Review and Meta-Analysis of Eight Randomized Trials
|
Yun, Seongseok
|
|
2016
|
16 |
6 |
p. e85-e94
nvt p.
|
artikel
|
| 4 |
Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib
|
Unnikrishnan, Radhika
|
|
2016
|
16 |
6 |
p. 366-371.e3
370635 p.
|
artikel
|
| 5 |
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma
|
Reagan, Patrick M.
|
|
2016
|
16 |
6 |
p. 322-328.e2
32479 p.
|
artikel
|
| 6 |
Cross-Intolerance With Dasatinib Among Imatinib-Intolerant Patients With Chronic Phase Chronic Myeloid Leukemia
|
Khoury, Hanna J.
|
|
2016
|
16 |
6 |
p. 341-349.e1
3150 p.
|
artikel
|
| 7 |
Cytogenetics and Survival of Multiple Myeloma: Isolated and Combined Effects
|
Sergentanis, Theodoros N.
|
|
2016
|
16 |
6 |
p. 335-340
6 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2016
|
16 |
6 |
p. A4-
1 p.
|
artikel
|
| 9 |
Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature
|
Foster, William R.
|
|
2016
|
16 |
6 |
p. 311-321
11 p.
|
artikel
|
| 10 |
Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse
|
Mlynarcikova, Miroslava
|
|
2016
|
16 |
6 |
p. 358-365
8 p.
|
artikel
|
| 11 |
Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms
|
Khan, Irum
|
|
2016
|
16 |
6 |
p. 350-357
8 p.
|
artikel
|
| 12 |
Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution
|
Magnano, Laura
|
|
2016
|
16 |
6 |
p. e71-e77
nvt p.
|
artikel
|
| 13 |
Table of Contents
|
|
|
2016
|
16 |
6 |
p. A5-
1 p.
|
artikel
|
| 14 |
VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
|
Siegel, David S.
|
|
2016
|
16 |
6 |
p. 329-334.e1
3012 p.
|
artikel
|
Tijdschrift beschrijving